NovaBay Pharmaceuticals, Inc. Made Headway
Fri, Sep 20, 2024 at 05:32 PM
NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT) jumped higher at $0.74, a gain of 48.9%. The stock got featured on our News Catalysts scanner on Fri, Sep 20, 2024 at 09:13 AM in the 'ACQUISITION' category. From Thu, Sep 05, 2024, the stock recorded 40.00% Up Days and 45.45% Green Days
The stock spiked on Fri, May 17, 2024 at $9.1 with a volume of 3M+.
About NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT)
NovaBay Pharmaceuticals Inc is a biopharmaceutical company engaged in commercializing & developing non-antibiotic anti-infective products to address the unmet therapeutic needs of the eye care market. Its product categories include NEUTROX & CELLERX.
Top 10 Gainers:
- Battalion Oil Corporation (BATL:NYSEMKT), 123.47%
- Banzai International, Inc. Class A Common Stock (BNZI:NASDAQ), 98.26%
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 84.62%
- JIN MEDICAL INTERNATIONAL LTD. (ZJYL:NASDAQ), 54.55%
- NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT), 48.92%
- Expion360 Inc. (XPON:NASDAQ), 45.7%
- Anebulo Pharmaceuticals Inc. (ANEB:NASDAQ), 39.37%
- CERo Therapeutics Holdings Inc Com (CERO:NASDAQ), 36.78%
- Alliance Entertainment Holding Corporation (AENT:NASDAQ), 33.82%
- Verb Technology Company, Inc. (VERB:NASDAQ), 33.09%